Artificial intelligence-driven rational design and optimization of a potent terpenoid-derived PCSK9 inhibitor
Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Computational Drug Discovery Methods
Cholinesterase and Neurodegenerative Diseases
Publication details
- Journal / source
- Molecular Diversity
- Publisher
- Springer Science and Business Media LLC
- Publication date
- 9 May 2026
- Language
- EN